Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  8.00 0.22% 3,566.00 3,560.00 3,564.00 3,586.00 3,542.00 3,542.00 109,734 15:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 515.1 40.9 32.9 108.5 3,863

Dechra Pharmaceuticals PLC Director/PDMR Shareholding

18/09/2020 7:00am

UK Regulatory (RNS & others)

Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart

From Aug 2020 to Oct 2020

Click Here for more Dechra Pharmaceuticals Charts.


RNS Number : 3618Z

Dechra Pharmaceuticals PLC

18 September 2020

18 September 2020

Dechra Pharmaceuticals PLC

Notification of Transactions by Persons Discharging Managerial Responsibilities

On 17 September 2020, Dechra Pharmaceuticals PLC was notified by a Director of the Company and Person Discharging Managerial Responsibilities that he had completed the sale of part of his beneficial interest in Dechra.

Julian Heslop, Non-Executive Director, has sold 4,000 ordinary shares in the Company. Following these transactions, Julian Heslop will continue to retain a beneficial holding of 6,000 ordinary shares which represents 0.006% of the current issued share capital in the Company.

The Notification of Dealing Form set out below are provided in accordance with Article 19.3 of MAR.

Notification of Dealing Form:

 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                   Julian Heslop 
     -------------------------------------  ---------------------------------- 
 2.   Reason for the notification 
 a)   Position/status                        Director 
     -------------------------------------  ---------------------------------- 
 b)   Initial notification/amendment         Initial Notification 
     -------------------------------------  ---------------------------------- 
 3.   Details of the Issuer 
 a)   Name                                   Dechra Pharmaceuticals PLC 
     -------------------------------------  ---------------------------------- 
 b)   LEI code                               213800J4UVB5OWG8VX82 
     -------------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of the financial           Ordinary Shares of 1 pence each 
       instrument                             ISIN: GB0009633180 
       Identification code 
     -------------------------------------  ---------------------------------- 
 b)   Nature of the transaction              Sale of Shares 
     -------------------------------------  ---------------------------------- 
 c)   Price(s) and volumes(s)                Price(s)            Volume(s) 
                                              GBP32.4826          4,000 
     -------------------------------------  ------------------  -------------- 
 d)        Aggregated information 
             *    Aggregate volume             4,000 
             *    Price 
             *    Total 
     -------------------------------------  ---------------------------------- 
 e)   Date of the transaction                17 September 2020 
     -------------------------------------  ---------------------------------- 
 f)   Place of the transaction               London Stock Exchange 
     -------------------------------------  ---------------------------------- 
 Dechra Pharmaceuticals PLC 
 Ian Page, Chief Executive                 Office: +44 (0) 1606 814 730 
 Paul Sandland, Acting Chief               Office: +44 (0) 1606 814 730 
  Financial Officer 
 TooleyStreet Communications 
 Fiona Tooley, Director                    Office: +44 (0) 121 309 0099 
  e-mail:            Mobile: +44 (0) 7785 703 523 
----------------------------------------  ------------------------------ 

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit:


Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

September 18, 2020 02:00 ET (06:00 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart
ADVFN Advertorial
Your Recent History
Dechra Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201025 04:45:16